View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Pharmatest
20 July 2016

Pharmatest’s Gain Access to Regus’ Global Network of Offices and Business Lounges

As well as opening new offices of its own in San Diego and Concord, Pharmatest Services has signed a service agreement with Regus to use its wide global network of offices and business lounges.

Pharmatest is a contract research organisation, which offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. Regus is a multinational corporation, which provides a global workspace, including office space and business lounges in 3000 locations worldwide.

Pharmatest started its current US sales strategy by opening its first office in the Boston area in early 2013. Since, the company has increased its annual US sales by 4-fold and the number of new US customer contacts by 6-fold.

The new offices will have an important role for contacting and serving customers in Boston and San Diego areas, which are both central locations of pharmaceutical industry. The new service agreement with Regus provides an excellent opportunity for Pharmatest to contact and serve customers in multiple locations in the US and elsewhere in the world.

CEO of Pharmatest Jussi Halleen comments: "Increasing US sales remains one major goal of Pharmatest for the coming years. The US sales strategy we started in 2013 has already shown its power. We have performed best possible activities and succeeded perfectly in them so far, and now we have taken the next steps to further boost our US sales. I am extremely happy with our new sales offices and the agreement with Regus, which will have an important role in achieving this goal."

4T1 is a triple-negative mouse breast cancer cell line. Pharmatest utilises a 4T1 cell line with stable expression of green fluorescent protein (GFP) enabling easy...
Metastatic and primary tumours are known to respond differently to chemotherapy. Therefore, when establishing drug efficacy it is important not to rely only on experiments...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology